Global Optic Neuropathy (Ophthalmology) Drugs In Development 2021 Market Report – Featuring Antoxis, Astellas Pharma and Quark Pharmaceuticals – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Optic Neuropathy (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling and clouding of vision. Predisposing factors include age, tobacco smoke, alcohol, cancer treating drugs, stress related chemicals, some ant